TRADING ON THE OTC - SYMBOL : PGUZ
OUR PRODUCTS : MEDICAL BACKGROUND & RESEARCH DATA : MANAGEMENT : INVESTORS/NEWS : LINKS : CONTACT US

 

 

 

 

 

 

Home Page  |  

April 18, 2011
PRESS RELEASE 

PEGASUS ACQUIRES U.S. PATENT FOR ITS HEARTVUE 6S SCREENING DEVICE; APPOINTS TWO EUROPEAN DISTRIBUTORS.
dot

November 3rd, 2008
PRESS RELEASE 

PEGASUS COMPLETES RESEARCH & DEVELOPMENT OF NEW, NON-INVASIVE HEARTVUE MONITORING SYSTEM FOR EMERGENCY ROOM ENVIRONMENTS.
dot

October 8th, 2008
PRESS RELEASE 

PEGASUS COMPLETES FIRST PHASE TESTING OF NON-TOXIC, ENVIRONMENTALLY-FRIENDLY, MOLD & MILDEW RESISTANT, WATER-BASED PAINT FOR A GROWING $10 BILLION MARKET.

August 18th, 2008
PRESS RELEASE 

CLINICAL STUDIES COMPLETED FOR HEARTVUE’S 6S SYSTEM HEART SCREENING SYSTEM.

July 16th, 2008
PRESS RELEASE 

NON-TOXIC, BIOLOGICAL ANTI-MOLD & MILDEW PRODUCT DISTRIBUTION AGREEMENT SIGNED BY PEGASUS’ NEW DISTRIBUTOR IN MEXICO.

June 9th, 2008
PRESS RELEASE 

PEGASUS RECEIVES FIRST LARGE PURCHASE ORDER FROM COMMANDER INTERNATIONAL FOR ITS INNOVATIVE, BIOLOGICAL TOXIC MOLD CONTROL PRODUCT.

March 27, 2008
PRESS RELEASE 

PEGASUS FILES PATENTS ON NEW BIOLOGICAL TOXIC MOLD CONTROL PRODUCT, OPENS LAB & APPOINTS DISTRIBUTOR FOR MARKETING TO MULTI-BILLION DOLLAR WORLDWIDE MOLD REMOVAL MARKET.

December 18, 2007
PRESS RELEASE 

HARVARD UNIVERSITY COMPLETES CLINICAL STUDY OF PEGASUS’ HEARTVUE 6S SYSTEM HEART SCREENING DEVICE.

January 8, 2007
PRESS RELEASE 

PEGASUS ACQUIRES WORLDWIDE MARKETING RIGHTS TO EFFECTIVE BIOLOGICAL-CONCEPT MOLD REMOVAL SYSTEM

November 30 , 2006
PRESS RELEASE 

PEGASUS/HEARTVIEW'S SCREENING DEVICE FOR HEART DISEASE RECEIVES MARKETING APPROVAL FOR EUROPEAN UNION .

October 30 , 2006
PRESS RELEASE 

PEGASUS/HEARTVIEW TO MARKET ITS HEARTVUE 6S SCREENING DEVICE IN EUROPE


June 27, 2006
PRESS RELEASE
PEGASUS/HEARTVIEW DELIVERS FIRST SHIPMENT OF 55 HEARTVUE 6S SYSTEM ELECTROCARDIOGRAPH UNITS TO CHINA


March 9th, 2006
PRESS RELEASE 

PEGASUS/HEARTVIEW DEMONSTRATES  HEARTVUE™ 6S SYSTEM CAPABILITIES AT THE ACC  55TH  SCIENTIFIC SESSION EXPOSITION IN ATLANTA, MARCH 11TH TO MARCH 14TH  (Booth #1855)

February 9th, 2006
PRESS RELEASE 
PEGASUS/HEARTVIEW SIGNS MULTI-YEAR SALES AGREEMENT WITH CHINA FOR ITS GROUND-BREAKING HeartVue™ 6S SYSTEM TECHNOLOGY.
Deliveries Of The Company's Non-Invasive Heart Screening System Are Expected To Exceed $ 50 Million USD.


July 14th, 2005
PRESS RELEASE:

PEGASUS/HEARTVIEW'S REVOLUTIONARY HEART SCREENING TECHNOLOGY PROVES ITS SPEED AND ACCURACY DURING NEW YORK PILOT STUDY

April 12, 2005
PRESS RELEASE:

PEGASUS/HEARTVIEW CLINICAL TRIAL FOR HEART DISEASE SCREENING DEVICE UNDERWAY IN NEW YORK

For more information, please contact:

Daniel P. Kesonen , Chairman & CEO
Pegasus Pharmaceuticals Inc.
& Heartview LLC

4400 PGA Blvd., Suite 900 ,
Palm Beach Gardens , FL U.S.A. 33410

Telephone: (561) 626-9901

Email: info@pegasusbiosciences.com

Issued & Outstanding Shares: 30,826,490
Transfer Agent: Stalt, Inc.   
671 Oak Grove Avenue,
Menlo Park, CA, U.S.A.  94025
(650) 321-7111

Email : info@stalt.com

 

 


Copyright © 2006, Pegasus Pharmaceuticals Inc.